At first, the researchers who discovered insulin agonized about whether to patent the drug at all.
About Scott Graves
This author has yet to write their bio.Meanwhile lets just say that we are proud Scott Graves contributed a whooping 13 entries.
Entries by Scott Graves
The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of a shakeup.
Insulin prices are soaring, creating pain for patients whose lives depend on the injectable drug—yet most of the revenue from the increases isn’t going to the drug manufacturers.
Robyn Curtis, a staff adviser at the University of Southern Mississippi in Hattiesburg, has a 13-year-old daughter with diabetes.
As U.S. drug prices rise, drugmakers are playing down their role, instead heaping blame on the middlemen who help determine how medicines are priced.
One reason Janine LePere is paying so much for insulin is that the LePere family has a high-deductible health plan.
The EpiPen isn’t the only life-saving medication that has experienced egregious price increases in the past decade…
Insulin is fast becoming a medication that only the well-insured or well-heeled diabetic can afford.
A new JAMA paper that says insulin prices have nearly tripled in a decade is making the internet rounds – and for good reason.
The cost of the hormone insulin, one of the most important treatments for diabetes, rose nearly 200 percent between 2002 and 2013, according to a new study.